We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Mechanism Allows Healthy Cells to Maintain Control of Cell Death Proteins

By Biotechdaily staff writers
Posted on 01 Jul 2008
Cancer researchers have identified a molecular mechanism that prevents apoptosis in healthy cells yet triggers cell death after critical DNA damage.

Investigators at the German Cancer Research Center [Deutsches Krebsforschungszentrum] (Heidelberg) worked with a series of "knockout” mice to examine the relationship between the HIPK2 tumor suppressor protein, an important regulator of cell death, and the E3 ubiquitin ligase Siah-1.

They reported in the June 8, 2008, online edition of the journal Nature Cell Biology that while healthy cells constantly produce HIPK2, it immediately binds to Siah-1, which induces HIPK2 polyubiquitination and subsequent destruction by the cell. More...
When normal cells suffer slight DNA damage, they block degradation of HIPK2 by Siah-1 for a short time. When the damage is repaired, the cell immediately resumes HIPK2 degradation. Only in severely damaged cells, such as those with a broken DNA double strand, is Siah-1 degradation of HIPK2 blocked permanently. As a result, HIPK2 accumulates, apoptosis is triggered, and the cell dies.

In some types of cancer cells this mechanism fails to operate. The degradation of HIPK2 by Siah-1 is not inhibited, and cells with damaged DNA proliferate instead of dying.

"Cancer medicine might be able to make use of our discovery,” said senior author Dr. Thomas G. Hofmann, a researcher at the German Cancer Research Center. "For example, we could use a Siah-1 blocker simultaneously with chemotherapy or radiotherapy to get the cells back into the apoptosis program.”


Related Links:
German Cancer Research Center

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.